Companies / Monte Rosa Therapeutics, Inc. / Activity
Activity — Monte Rosa Therapeutics, Inc.
29 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Dunn Edmund Executive | Sell | Common Stock | $455.5K | -25K -52.58% | 22,693 0.03% of shares | medium |
| Feb 27, 2026 | Dunn Edmund Executive | Exercise | Common Stock | $337.4K | +25K +110.89% | 47,857 0.06% of shares | low |
| Feb 23, 2026 | Janku Filip Executive | Sell | Common Stock | $179.2K | -9K -12.25% | 65,837 0.08% of shares | medium |
| Jan 5, 2026 | Warmuth Markus CEO | Sell | Common Stock | $153.7K | -10K -1.60% | 624,403 0.73% of shares | medium |
| Mar 2, 2026 | Warmuth Markus CEO | Sell | Common Stock | $98.0K | -5K -0.88% | 613,471 0.72% of shares | low |
| Jan 7, 2026 | Warmuth Markus CEO | Sell | Common Stock | $86.2K | -4K -0.59% | 620,696 0.73% of shares | low |
| Jan 5, 2026 | Nickson Philip Executive | Sell | Common Stock | $47.9K | -3K -4.93% | 60,845 0.07% of shares | low |
| Jan 5, 2026 | Janku Filip Executive | Sell | Common Stock | $47.9K | -3K -4.04% | 75,026 0.09% of shares | low |
| Jan 5, 2026 | Townson Sharon Executive | Sell | Common Stock | $47.9K | -3K -4.44% | 67,845 0.08% of shares | low |
| Jan 5, 2026 | Champoux Jennifer Executive | Sell | Common Stock | $39.9K | -3K -4.04% | 62,371 0.07% of shares | low |
| Jan 7, 2026 | Warmuth Markus CEO | Sell | Common Stock | $34.6K | -1K -0.23% | 619,246 0.73% of shares | low |
| Jan 5, 2026 | Dunn Edmund Executive | Sell | Common Stock | $15.8K | -1K -4.38% | 22,693 0.03% of shares | low |
| Mar 2, 2026 | Dunn Edmund Executive | Sell | Common Stock | $9.4K | -536 -2.31% | 22,693 0.03% of shares | low |
| Jan 7, 2026 | Warmuth Markus CEO | Sell | Common Stock | $7.6K | -309 -0.05% | 618,937 0.73% of shares | low |
| Mar 2, 2026 | Dunn Edmund Executive | Exercise | Common Stock | $7.2K | +536 +2.36% | 23,229 0.03% of shares | low |
| Mar 4, 2026 | Dunn Edmund Executive | Sell | Common Stock | $2.5K | -139 -0.61% | 22,554 0.03% of shares | low |
| Jun 11, 2026 | Schiff Andrew N Director | Grant | Stock Option (Right to Buy) | — | +26K | 25,800 0.03% of shares | low |
| Mar 2, 2026 | Dunn Edmund Executive | Exercise | Stock Option (Right to Buy) | — | -536 -100.00% | 0 0.00% of shares | low |
| Feb 27, 2026 | Dunn Edmund Executive | Exercise | Stock Option (Right to Buy) | — | -25K -97.91% | 536 <0.01% of shares | low |
| Jan 2, 2026 | Nickson Philip Executive | Grant | Stock Option (Right to Buy) | — | +126K | 126,000 0.15% of shares | low |
| Jan 2, 2026 | Nickson Philip Executive | Grant | Common Stock | — | +28K +77.78% | 64,000 0.08% of shares | low |
| Jan 2, 2026 | Champoux Jennifer Executive | Grant | Stock Option (Right to Buy) | — | +158K | 158,000 0.19% of shares | low |
| Jan 2, 2026 | Champoux Jennifer Executive | Grant | Common Stock | — | +35K +116.67% | 65,000 0.08% of shares | low |
| Jan 2, 2026 | Warmuth Markus CEO | Grant | Stock Option (Right to Buy) | — | +406K | 406,000 0.48% of shares | low |
| Jan 2, 2026 | Warmuth Markus CEO | Grant | Common Stock | — | +90K +16.53% | 634,538 0.74% of shares | low |
| Jan 2, 2026 | Janku Filip Executive | Grant | Stock Option (Right to Buy) | — | +139K | 139,000 0.16% of shares | low |
| Jan 2, 2026 | Janku Filip Executive | Grant | Common Stock | — | +31K +65.70% | 78,181 0.09% of shares | low |
| Jan 2, 2026 | Townson Sharon Executive | Grant | Stock Option (Right to Buy) | — | +158K | 158,000 0.19% of shares | low |
| Jan 2, 2026 | Townson Sharon Executive | Grant | Common Stock | — | +35K +97.22% | 71,000 0.08% of shares | low |